Filling in the Gaps: Updates on Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections.

Area of Science:

• Public Health
• Infectious Diseases
• Epidemiology

Background:

• Sexually transmitted infections (STIs) including syphilis, gonorrhea, and chlamydia are increasing in the US.
• These rising STI rates disproportionately affect gay, bisexual, and other men who have sex with men (MSM) and racial/ethnic minorities.

Purpose of the Study:

• To review current evidence on doxycycline post-exposure prophylaxis (doxy-PEP) for bacterial STI prevention.
• To examine doxy-PEP's efficacy, safety, impact on antimicrobial resistance (AMR), acceptability, and population-level effects.

Main Methods:

• This is a review article, synthesizing existing research and data.
• The review covers efficacy studies, safety profiles, AMR considerations, user acceptability, and population impact modeling.

Main Results:

• Doxy-PEP demonstrates efficacy in preventing bacterial STIs among key populations.
• Evidence on safety, antimicrobial resistance (AMR) implications, and user acceptability is being gathered and analyzed.
• Modeling suggests potential population-level impact on STI incidence.

Conclusions:

• Doxy-PEP is an emerging tool for bacterial STI prevention, particularly for MSM and other at-risk groups.
• Equitable implementation requires careful consideration of access, usage patterns, provider education, and community engagement.
• Ongoing monitoring of STI incidence and AMR is essential to guide future use and policy.